Cell and gene therapies offer new opportunities for treatments in areas of high un-met medical need. But such cutting edge therapeutics need cutting edge technology. OneNucleus’ BioWednesday Webinar will focus on the exciting scientific technologies and tools which are needed to develop cell and gene therapies, and ultimately improve patient outcomes. Presentations will be followed by a wider Q&A session where there will be a chance to ask further questions around the specific value chain activities covered.
Mogrify® has developed a proprietary suite of platform technologies that enable systematic identification of the key transcriptomic and epigenetic switches that drive the speed, efficiency and maintenance of cell conversions.